Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.

Biotech execs express concerns over FDA changes, NIH cuts, and Trump's tariffs. Industry confidence low amid poor funding ...

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

This week ended up as a pretty active one for large startup financings. AI and biotech were the biggest areas for funding, ...

The key to biotech is finding companies with lots of cash and promising ... a market value under $200 million—compared with about $100 million of cash. Jefferies analyst Maury Raycroft favors ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Biotech was born, creating a boom in American jobs ... UCSF faculty registered 171 new scientific inventions in 2024, while nearly 100 were licensed to companies for development. Examples of ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.